4.7 Article

Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities

期刊

EUROPEAN JOURNAL OF CANCER
卷 49, 期 9, 页码 2179-2186

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2013.01.018

关键词

HPV; Screening; Triage; Cervical disease

类别

资金

  1. Cancer Research UK [C569/A10404, C8162/A10406]
  2. Qiagen
  3. Gen-Probe Incorporated
  4. Abbott Molecular
  5. BD Diagnostics
  6. NorChip
  7. mtm laboratories
  8. Roche Diagnostics
  9. Genera
  10. BD Diagnostics Roche Diagnostics
  11. Ventana
  12. Hologic
  13. Merck

向作者/读者索取更多资源

Aim: To compare triage strategies using different human papillomavirus (HPV) consensus and genotyping tests and a p16(INK4a) test. Methods: 1228 women referred with a borderline or single mildly dyskaryotic smear. Samples were taken at colposcopy using PreservCyt. Tests included Hybrid Capture 2, Abbott Real-Time PCR, BD HPV, CobasW 4800, PreTect HPV-Proofer, APTIMA and p16(INK4a). Results were based on the worst histology within 9 months. Results: 97/1228 (7.9%) women had CIN3+ (203/1228 (17%) CIN2+). HPV testing alone using Hybrid Capture 2, Abbott RealTime PCR, BD HPV, Cobas 4800 or APTIMA had a sensitivity for CIN3+ ranging from 99.0% to 100.0% and specificity for

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据